FTRE - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 1.9x as much as the broader market.

Beta (Market Relation)

1.91x

Above average

Volatility (3Y p.a.)

73.6% p.a.

Fallback

Max Drawdown (3Y)

-89.9%

Fallback

Sharpe Ratio

-0.17

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+101.1%
3 Years	73.6%	-89.9%	-0.17	-10.1%
5 Years	—	—	—	—
10 Years	—	—	—	—

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 213%.

Unprofitable business model: The company is currently generating net losses.

High market risk: Beta of 1.91 indicates above-average volatility compared to the broader market.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)

Overall Governance Risk

4 ISS Score: 4 / 10

Audit Risk

9 ISS Score: 9 / 10

Board Risk

2 ISS Score: 2 / 10

Short Ratio

10.99